CLINICAL_TRIALS
trial_result
· 2014-02-27
Clinical Trial Update: Lenalidomide as Chemoprevention in Treating Patients With High-Risk, Early-Stage B-Cell Chronic Lymphocytic Leukemia [NA]
Summary
A terminated clinical trial evaluating lenalidomide as chemoprevention in high-risk, early-stage B-cell chronic lymphocytic leukemia has posted results. The stu…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Roswell Park Cancer Institute | Conditions: B-cell Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia | NA | Status: TERMINATED | Results posted: 2014-02-27